Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

HIGHLIGHTS

• who: Crismita Dmello from the Intracranial immunocompetent mouse model The protocol (IS00015286) for intracranial implantation and monitoring of animals was approved by the IACUC at Northwestern UniversityBoth wild-type C BL/, and , KO Mice were housed in pathogen-free conditions at a relatively constant temperature of , u00b0C and humidity of, %. , to , weeks old male and female wild-type C BL/, mice purchased from the Charles River Laboratories and , KO mice (B6., Cd8atm Mak/J have published the research: Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade, in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.